Conversely, in a cohort study by Tulinius et al. [35] no familial risk due to BRCA2 gene mutations was found for pancreatic cancer among breast cancer patients, yet, it was evident for cancers of the stomach, prostate and kidneys. The gene discussed is BRCA2; the disease is breast carcinoma.